Plasma, the yellowish liquid part of the blood, could help in the recovery of critically ill Covid-19 patients | Representation image | Pexels
Plasma, the yellowish liquid part of the blood, could help in the recovery of critically ill Covid-19 patients | representational image | Pexels
Text Size:

Bengaluru: A city based private hospital has been given the nod by Indian Council of Medical Research to conduct clinical trials on COVID-19 patients using plasma therapy.

This was stated by the Drugs Controller General of India in a letter to to HCG Bangalore Institute of Oncology Speciality Centre.

The permission was granted on Monday under the provisions of New Drugs and Clinical Trial Rules, 2019.

“Grant of permission given to conduct clinical study in India entitled “Open label, parallel arm, Phase I/II Clinical Trial to evaluate safety and efficacy of Convalescent plasma as therapy for COVID-19 Severe SARS-Cov-2 Disease,” DCGI Dr V G Somani said in the letter.

Sharing the letter on his Twitter handle, the Minister for Medical Education, Dr K Sudhakar, who himself is a medical professional, wrote, “Plasma therapy holds great promise in treating Covid-19 patients and I am happy to inform ICMR agreed to our request and has given permission for plasma treatment to Dr. Vishal Rao, HCG Bangalore Inst of Oncology.”

Sudhakar tagged Prime Minister Narendra Modi, Home Minister Amit Shah, BJP national president J P Nadda and Chief Minister B S Yediyurappa while sharing the information.


Also read: HIV-drug combo, touted as a promising Covid-19 treatment, fails clinical trial


 

Subscribe to our channels on YouTube & Telegram

News media is in a crisis & only you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.

At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.

Support Our Journalism

Share Your Views

LEAVE A REPLY

Please enter your comment!
Please enter your name here